Jesse Goodman

Dr. Jesse Goodman is revolutionizing practices in infectious diseases and public health through his dynamic role as a professor in the School of Medicine and as the director of the Georgetown Center on Medical Product Access, Safety, and Stewardship (COMPASS) at Georgetown University. With a career that spans decades, Dr. Goodman has made significant contributions to the field, particularly during his tenure as the chief scientist of the U.S. Food and Drug Administration (FDA) from 2009 to 2014. During this period, he was instrumental in leading the FDA's response to the 2009 H1N1 pandemic, showcasing his expertise in managing public health crises. Before his role as chief scientist, Dr. Goodman directed the FDA's Center for Biologics Evaluation and Research from 2003 to 2009. In this capacity, he oversaw critical advancements in the evaluation and regulation of biological products, ensuring their safety and efficacy for public use. His leadership in these roles has been pivotal in shaping policies and practices that enhance the safety and accessibility of medical products. Dr. Goodman's academic and professional achievements have earned him recognition from prestigious organizations. He has been elected to the American Society for Clinical Investigation, a testament to his contributions to clinical research and public health. Additionally, his election to the National Academy of Medicine of the National Academy of Sciences underscores his influence and impact in the scientific community. At Georgetown University, Dr. Goodman continues to drive innovation and excellence in the field of infectious diseases. His work at COMPASS focuses on improving access to safe and effective medical products, a mission that aligns with his lifelong dedication to public health and safety. Through his research and leadership, Dr. Goodman is committed to advancing knowledge and practices that protect and improve global health. Dr. Goodman's career is marked by a commitment to public service and a passion for addressing complex health challenges. His contributions extend beyond academia and regulatory roles, as he actively engages in initiatives that promote health equity and access to medical innovations. His work exemplifies a blend of scientific rigor and compassionate care, making a lasting impact on the field of infectious diseases. As a thought leader and advocate for public health, Dr. Goodman continues to inspire the next generation of medical professionals and researchers. His dedication to fostering a collaborative and innovative environment at Georgetown University ensures that his legacy will endure, influencing future advancements in medicine and public health.